Kidney Cancer

KidneyA Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
KidneyA First-in-Human, Phase 1 Dose Escalation and Dose Expansion Trial to Assess the Safety and Tolerability of COM503 as Monotherapy and in Combination Therapy in Participants With Advanced Solid Malignancies
Kidney, PediatricsRisk Adapted Treatment of Unilateral Favorable Histology Wilms Tumors (FHWT)
Cervix, Colon, Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Lung, Phase I, Rectum, Small Intestine, Stomach, ThyroidA Phase 1, Open-label, Multicenter, Dose Escalation Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of KQB168 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Malignancies
Esophagus, Kidney, Larynx, Lip, Oral Cavity and Pharynx, Lung, Melanoma, Skin, Urinary BladderAn Open-Label, Phase 1 Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AB821 in Adult Participants With Locally Advanced or Metastatic Melanoma and Other Solid Tumors